Literature DB >> 14632759

Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.

M Eck1, B Schmausser, K Scheller, S Brändlein, H K Müller-Hermelink.   

Abstract

CXC chemokines modulate host immunity, neovascularization, growth and invasive behaviour of tumours. Despite their relevance in tumour biology, chemokine expression in intestinal- and diffuse-type gastric carcinoma, which exhibit a completely different growth pattern, has not been investigated in detail. In this study, expression of the CXC chemokines CXCL8 [interleukin (IL)-8], CXCL1 [growth-related oncogene alpha (Gro alpha)], CXCL9 [monokine induced by interferon (IFN)-gamma] and CXCL10 [IFN-gamma-inducible protein-10 (IP-10)] and the corresponding chemokine receptors CXCR1-3 was investigated by immunohistochemistry in intestinal- and diffuse-type gastric carcinoma. Tumour cells of all patients expressed CXCL8. CXCL8 expression was significantly stronger in tumour cells of diffuse- rather than intestinal-type gastric carcinoma (P < 0.01) as determined by a semiquantitative score. CXCL1 was expressed almost exclusively by diffuse- but not intestinal-type carcinoma cells. The corresponding chemokine receptors, CXCR1 and CXCR2, were found on carcinoma cells. Furthermore, CXCL8 expression correlated with number of tumour vessels (P < 0.01), suggesting an angiogenetic function in gastric carcinoma not only in vitro but also in vivo. CXCL10 and CXCL9, attractants for T cells, were expressed by peritumorous macrophages in close proximity to IFN-gamma-producing CXCR3-positive T cells in both tumour types. These chemokines may attract gastric carcinoma-infiltrating T cells via an IFN-gamma-mediated pathway and enhance host immunity against the tumour. In gastric carcinoma a complex interplay between CXC-chemokine signals derived from both tumour cells and tumour-infiltrating immune cells may exhibit pleiotropic effects in tumour biology that go far beyond their originally described functions as leucocyte chemoattractants. Because CXCL8 and CXCL1, which are known to increase growth and invasive behaviour of malignant tumours, are significantly stronger expressed in diffuse- than intestinal-type gastric carcinoma, one may speculate that these chemokines influence the different growth pattern of gastric carcinoma types.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14632759      PMCID: PMC1808898          DOI: 10.1111/j.1365-2249.2003.02305.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Chemokines: not just leukocyte chemoattractants in the promotion of cancer.

Authors:  R M Strieter
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 2.  The biology of chemokines and their receptors.

Authors:  D Rossi; A Zlotnik
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis.

Authors:  M Eck; B Schmausser; K Scheller; A Toksoy; M Kraus; T Menzel; H K Müller-Hermelink; R Gillitzer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

4.  Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers.

Authors:  J Fujimoto; H Sakaguchi; I Aoki; T Tamaya
Journal:  Cancer Res       Date:  2000-05-15       Impact factor: 12.701

5.  [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue].

Authors:  W Remmele; H E Stegner
Journal:  Pathologe       Date:  1987-05       Impact factor: 1.011

Review 6.  Infections as a major preventable cause of human cancer.

Authors:  H Kuper; H O Adami; D Trichopoulos
Journal:  J Intern Med       Date:  2000-09       Impact factor: 8.989

7.  Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.

Authors:  K Inoue; J W Slaton; B Y Eve; S J Kim; P Perrotte; M D Balbay; S Yano; M Bar-Eli; R Radinsky; C A Pettaway; C P Dinney
Journal:  Clin Cancer Res       Date:  2000-05       Impact factor: 12.531

Review 8.  CXC chemokines in angiogenesis.

Authors:  J A Belperio; M P Keane; D A Arenberg; C L Addison; J E Ehlert; M D Burdick; R M Strieter
Journal:  J Leukoc Biol       Date:  2000-07       Impact factor: 4.962

9.  Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8.

Authors:  Y Kitadai; K Haruma; N Mukaida; Y Ohmoto; N Matsutani; W Yasui; S Yamamoto; K Sumii; G Kajiyama; I J Fidler; E Tahara
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

10.  Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice.

Authors:  Y Kitadai; Y Takahashi; K Haruma; K Naka; K Sumii; H Yokozaki; W Yasui; N Mukaida; Y Ohmoto; G Kajiyama; I J Fidler; E Tahara
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

View more
  45 in total

1.  The parity-associated microenvironmental niche in the omental fat band is refractory to ovarian cancer metastasis.

Authors:  Courtney A Cohen; Amanda A Shea; C Lynn Heffron; Eva M Schmelz; Paul C Roberts
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-10

2.  PCAF acts as a gastric cancer suppressor through a novel PCAF-p16-CDK4 axis.

Authors:  Hong-Jun Fei; Li-Dong Zu; Jun Wu; Xiao-Shu Jiang; Jing-Long Wang; Y Eugene Chin; Guo-Hui Fu
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

Review 3.  Neutrophils: key mediators of tumour angiogenesis.

Authors:  Simon Tazzyman; Claire E Lewis; Craig Murdoch
Journal:  Int J Exp Pathol       Date:  2009-06       Impact factor: 1.925

4.  A digest on the role of the tumor microenvironment in gastrointestinal cancers.

Authors:  Martin Augsten; Christina Hägglöf; Cristina Peña; Arne Ostman
Journal:  Cancer Microenviron       Date:  2010-03-07

5.  The tumor microenvironment in colorectal carcinogenesis.

Authors:  Vijay G Peddareddigari; Dingzhi Wang; Raymond N Dubois
Journal:  Cancer Microenviron       Date:  2010-03-05

Review 6.  CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.

Authors:  Hyo Jin Lee; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis.

Authors:  Sandeep K Raghuwanshi; Nikia Smith; Elizabeth J Rivers; Ariel J Thomas; Natalie Sutton; Yuhui Hu; Somnath Mukhopadhyay; Xiaoxin L Chen; TinChung Leung; Ricardo M Richardson
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

8.  PAI-1 leads to G1-phase cell-cycle progression through cyclin D3/cdk4/6 upregulation.

Authors:  Evan Gomes Giacoia; Makito Miyake; Adrienne Lawton; Steve Goodison; Charles J Rosser
Journal:  Mol Cancer Res       Date:  2014-01-24       Impact factor: 5.852

9.  Upregulation of C-X-C chemokine receptor type 1 expression is associated with late-stage gastric adenocarcinoma.

Authors:  Jun Pu Wang; Wan Ming Hu; Kuan Song Wang; Bai Hua Luo; Chang Wu; Zhi Hong Chen; Geng Qiu Luo; Yu Wu Liu; Qin Lai Liu; Jun Yu; Jing He Li; Ji Fang Wen
Journal:  Exp Ther Med       Date:  2012-05-07       Impact factor: 2.447

10.  Myeloid cells in the tumor microenvironment: modulation of tumor angiogenesis and tumor inflammation.

Authors:  Michael C Schmid; Judith A Varner
Journal:  J Oncol       Date:  2010-05-16       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.